(Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS on: February 23, 2020, 03:20:27 pm #1 From PubMed (February 23, 2020), "ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis" ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis - PubMed Alemtuzumab is highly effective in relapsing remitting multiple sclerosis (RRMS), but autoimmune adverse events are of concern. In contrast to rare cases of immune-mediated cutaneous vasculitis, sy... PubMed · ncbi.nlm.nih.gov ANCA vasculitis:QuoteANCA vasculitis is an autoimmune disease affecting small blood vessels in the body. It is caused by autoantibodies called ANCAs, or [/size]A[/color][/size]nti-[/color][/size]N[/color][/size]eutrophilic [/color][/size]C[/color][/size]ytoplasmic [/color][/size]A[/color][/size]utoantibodies. ANCAs target and attack a certain kind of white blood cells called neutrophils. They target a part of neutrophils called the cytoplasm (the inside of the cell.)[/color][from the UNC Kidney Center Website] Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
